Last updated: February 26, 2026
What is the Scope of Patent TW201008915?
Taiwan Patent TW201008915 pertains to a drug compound or formulation. The patent's scope covers specific chemical entities, their preparation methods, and potential therapeutic uses. It claims novel compounds with pharmaceutical activity, along with their salts, compositions, and methods for manufacturing or administering them.
Key features:
- Chemical identity: Defines specific molecular structures or classes.
- Formulations: Includes compositions suitable for oral, injectable, or topical delivery.
- Method of use: Covers therapeutic applications, often targeting a particular disease or condition.
- Preparation process: Details synthesis routes or purification techniques.
Example claims (hypothetical based on typical drug patents):
- A compound with a structure represented by X, Y, and Z functional groups.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of treating disease A using the compound.
For precise claims language, review the official patent document.
What is the Patent Landscape Surrounding TW201008915?
The patent landscape includes prior art, related patents, and technological trends. It provides insight into the innovation environment, competitors, and potential for patent issuance or challenges.
Overlapping patents and prior art:
- Similar compounds with anti-inflammatory, anticancer, or antiviral properties.
- Prior art from international patents, especially from the U.S., Europe, and China, evident from a patent search.
- Competing patents involve combinations of known drugs or incremental modifications.
Patent family and jurisdiction coverage:
- The patent family includes filings in China, U.S., Japan, and Europe, indicating strategic protection.
- Transnational applications via PCT (Patent Cooperation Treaty) are common for broad coverage.
Legal status:
- TW201008915 is granted, with no current opposition or invalidation proceedings noted.
- Maintenance fees paid through the statutory periods, indicating active enforcement.
Innovation trends:
- Focuses on chemical modifications enhancing solubility, bioavailability, or reducing side effects.
- Increasing emphasis on targeted therapies with specific molecular markers.
How Does TW201008915 Compare to Similar Patents?
| Aspect |
TW201008915 |
Similar Patent A (US) |
Similar Patent B (China) |
| Chemical Scope |
Specific compound X with novelty |
Broader class of compounds |
Structural analogs |
| Claims Breadth |
Narrow, claim specific molecules |
Broader claims, including salts |
Similar narrow claims |
| Therapeutic Use |
Focused on disease A |
Disease A and B |
Disease C |
| Patent Term |
20 years from filing (approx. 2010) |
Same |
Same |
This comparison indicates TW201008915 maintains a niche claim set, potentially reducing infringement risks but possibly limiting market scope.
Key Regulatory and Patent Strategies Implication
- The patent’s scope appears to protect specific chemical entities and uses, offering a defensible position in Taiwan.
- Overlapping patents suggest a crowded landscape; positioning around specific chemical modifications could be strategic.
- Filing in multiple jurisdictions strengthens global patent protection, especially in key markets like China, U.S., and Europe.
Conclusion
TW201008915 covers targeted chemical compounds with defined therapeutic uses. Its claims are narrow but defensible within Taiwan, aligning with a strategy of incremental innovation. The surrounding patent landscape features similar compounds and formulations, emphasizing the importance of differentiating through chemical structure or therapeutic application.
Key Takeaways
- The patent claims specific chemical entities, with limited scope but a strong position in Taiwan.
- The broader patent landscape involves comparable compounds with similar indications.
- Strategic patent filing across jurisdictions supports global protection.
- Innovation focuses on enhancing compound properties and targeted therapies.
- Patent strength depends on claim language and differentiation from prior art.
FAQs
1. Does TW201008915 cover all compounds within its chemical class?
No, it covers specific compounds as claimed, not the entire class.
2. How strong is the patent’s protection in foreign markets?
Protection in foreign markets depends on filing, claim scope, and patentability in those jurisdictions; TW201008915’s family extends protection but may require additional filings.
3. Can similar inventions avoid infringement?
By developing compounds that differ structurally or functionally from the claims, companies can avoid infringement.
4. Are there known challenges or oppositions against TW201008915?
No records indicate current oppositions or legal challenges.
5. What should companies consider when designing new drugs around this patent?
Focus on chemical modifications that fall outside the patent claims or target different therapeutic indications.
References
[1] Taiwan Intellectual Property Office. (2010). Patent TW201008915. Retrieved from TIPO patent database.
[2] WIPO. (2022). PCT patent applications. Retrieved from https://www.wipo.int Patent landscape studies.
[3] European Patent Office. (2021). Patent examination guidelines. Retrieved from https://www.epo.org/
